Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

Relative to several other toll-like receptor (TLR) agonists, we found polyinosinic:polycytidylic acid (poly IC) to be the most effective adjuvant for Th1 CD4+ T cell responses to a dendritic cell (DC)–targeted HIV gag protein vaccine in mice. To identify mechanisms for adjuvant action in the intact animal and the polyclonal T cell repertoire, we found poly IC to be the most effective inducer of type I interferon (IFN), which was produced by DEC-205+ DCs, monocytes, and stromal cells. Antibody blocking or deletion of type I IFN receptor showed that IFN was essential for DC maturation and development of CD4+ immunity. The IFN-AR receptor was directly required for DCs to respond to poly IC. STAT 1 was also essential, in keeping with the type I IFN requirement, but not type II IFN or IL-12 p40. Induction of type I IFN was mda5 dependent, but DCs additionally used TLR3. In bone marrow chimeras, radioresistant and, likely, nonhematopoietic cells were the main source of IFN, but mda5 was required in both marrow–derived and radioresistant host cells for adaptive responses. Therefore, the adjuvant action of poly IC requires a widespread innate type I IFN response that directly links antigen presentation by DCs to adaptive immunity.

[1]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[2]  R. Steinman,et al.  Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques , 2009, PLoS pathogens.

[3]  R. Steinman,et al.  CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells1 , 2008, The Journal of Immunology.

[4]  F. Sallusto,et al.  Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation , 2008, European journal of immunology.

[5]  C. Alonso,et al.  Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. , 2008, Microbes and infection.

[6]  D. Monack.  Faculty Opinions recommendation of Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. , 2008 .

[7]  F. Re,et al.  Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31 , 2008, The Journal of Immunology.

[8]  Henk C. Hoogsteden,et al.  Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.

[9]  R. Steinman,et al.  The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine , 2008, Proceedings of the National Academy of Sciences.

[10]  G. Randolph,et al.  Antigen presentation by monocytes and monocyte-derived cells. , 2008, Current opinion in immunology.

[11]  M. Colonna,et al.  Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells , 2007, The Journal of experimental medicine.

[12]  B. Pulendran,et al.  The science of adjuvants , 2007, Expert review of vaccines.

[13]  J. Farrar,et al.  IFN-α Is Not Sufficient to Drive Th1 Development Due to Lack of Stable T-bet Expression1 , 2007, The Journal of Immunology.

[14]  S. Akira,et al.  Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. , 2007, Immunity.

[15]  Thomas C. Mitchell,et al.  The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.

[16]  M. Nolte,et al.  Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo , 2007, The Journal of experimental medicine.

[17]  L. Vitale,et al.  Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity1 , 2007, The Journal of Immunology.

[18]  S. Akira,et al.  Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. , 2007, International immunology.

[19]  D. Gabrilovich,et al.  Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. , 2007, Blood.

[20]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[21]  L. Moldawer,et al.  Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA. , 2006, Immunology letters.

[22]  Rino Rappuoli,et al.  Vaccine manufacturing: challenges and solutions , 2006, Nature Biotechnology.

[23]  T. Heng,et al.  De novo production of antigen-specific suppressor cells in vivo , 2006, Nature Protocols.

[24]  W. Gillanders,et al.  The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. , 2006, Vaccine.

[25]  A. Ashkar,et al.  The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. , 2006, Cellular immunology.

[26]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[28]  D. Tough,et al.  Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1 , 2006, The Journal of Immunology.

[29]  C. Havenar-Daughton,et al.  Cutting Edge: The Direct Action of Type I IFN on CD4 T Cells Is Critical for Sustaining Clonal Expansion in Response to a Viral but Not a Bacterial Infection1 , 2006, The Journal of Immunology.

[30]  Bali Pulendran,et al.  Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.

[31]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[32]  Bruce S. Thompson,et al.  The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells , 2005, Journal of leukocyte biology.

[33]  L. Zitvogel,et al.  Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.

[34]  K. Takeda.  [Toll-like receptor]. , 2005, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[35]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[36]  L. Moretta,et al.  NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor , 2005 .

[37]  Francesco Bertoni,et al.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.

[38]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[39]  S. Durham,et al.  Monophosphoryl lipid A (MPL®) * promotes allergen‐induced immune deviation in favour of Th1 responses , 2005, Allergy.

[40]  G. Trinchieri,et al.  Type I interferon dependence of plasmacytoid dendritic cell activation and migration , 2005, The Journal of experimental medicine.

[41]  C. Sousa,et al.  Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function , 2005, Nature Immunology.

[42]  R. Flavell,et al.  TLR-Independent Induction of Dendritic Cell Maturation and Adaptive Immunity by Negative-Strand RNA Viruses1 , 2004, The Journal of Immunology.

[43]  Antonio Lanzavecchia,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.

[44]  J. Farrar,et al.  Frontline: Absence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN‐α , 2004, European journal of immunology.

[45]  A. Mazzoni,et al.  Controlling the Toll road to dendritic cell polarization , 2004, Journal of leukocyte biology.

[46]  P. Borrow,et al.  Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.

[47]  S. Akira,et al.  Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Steinman,et al.  Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .

[49]  Michel C. Nussenzweig,et al.  Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.

[50]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2002, Nature Immunology.

[51]  Ion Gresser,et al.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation. , 2002, Blood.

[52]  A. Sher,et al.  T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[54]  T. Di Pucchio,et al.  Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. , 2001, Blood.

[55]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[56]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[57]  J. Webb,et al.  Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18. , 2001, Cellular immunology.

[58]  M. Kurimoto,et al.  IFN‐α  and IL‐18 synergistically enhance IFN‐γ  production in human NK cells: differential regulation of Stat4 activation and IFN‐γ  gene expression by IFN‐α  and IL‐12 , 2001 .

[59]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[60]  G. Melioli,et al.  HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. , 2001, Immunology letters.

[61]  T. Di Pucchio,et al.  Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.

[62]  I. Weissman,et al.  In vivo natural killer cell activities revealed by natural killer cell-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[64]  R. Verdijk,et al.  Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.

[65]  N. Lycke,et al.  Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. , 1999, Journal of immunology.

[66]  M. Caligiuri,et al.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.

[67]  P. Marrack,et al.  Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.

[68]  R. Zinkernagel,et al.  IL-12 is not required for induction of type 1 cytokine responses in viral infections. , 1999, Journal of immunology.

[69]  S. Akira,et al.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.

[70]  A. N. Park,et al.  Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells , 1998, Journal of leukocyte biology.

[71]  K. Pang,et al.  Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.

[72]  B. Haagmans,et al.  Mice lacking IL-12 develop polarized Th1 cells during viral infection. , 1998, Journal of immunology.

[73]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[74]  M. Biffi,et al.  Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells , 1997, The Journal of experimental medicine.

[75]  J. Sprent,et al.  Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.

[76]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[77]  K. Murphy,et al.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. , 1996, Journal of immunology.

[78]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[79]  G. Trinchieri,et al.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.

[80]  P. Musiani,et al.  IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. , 1994, Journal of immunology.

[81]  A. Sher,et al.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.

[82]  C. Heusser,et al.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.

[83]  V. Devita,et al.  A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. , 1976, Journal of the National Cancer Institute.

[84]  D. Burke,et al.  Studies on the production, mode of action and properties of interferon. , 1957, British journal of experimental pathology.

[85]  Y NAGANO,et al.  [Immunizing property of vaccinia virus inactivated by ultraviolets rays]. , 1954, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[86]  熊谷 雄太郎,et al.  Alveolar macrophages are the primary interferon-α producer in pulmonary infection with RNA viruses , 2008 .

[87]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[88]  J. Mascola,et al.  2 – IMMUNOLOGY: PART A. Basic Immunology of Vaccine Development , 2003 .

[89]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2003, Nature Immunology.

[90]  R. Koup,et al.  Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses , 2003 .

[91]  Jianfei Yang,et al.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.

[92]  E. Raz,et al.  Cross-Priming of CD8 + T Cells by Immunostimulatory Sequence DNA , 2002 .

[93]  J. de Maeyer-Guignard,et al.  Type I interferons. , 1998, International reviews of immunology.

[94]  B. Devulder.  L'union fait la force… , 1994 .

[95]  S. Hammar.  Langerhans cells. , 1988, Pathology annual.